Frank Witney - 04 Apr 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: Director
Signature: /s/ Frank Witney by Nicholas Khadder, Attorney-in-Fact
Issuer symbol: LAB
Transactions as of: 04 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Apr 2022, 18:35:26 UTC
Previous filing: 17 Jun 2021
Next filing: 09 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock	Award	$0	+15,852		$0.000000	15,852	04 Apr 2022	Direct	F1
holding	LAB	Common Stock						4,225	04 Apr 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LAB	Stock Option (Right to Buy)	Award	$0	+23,401		$0.000000	23,401	04 Apr 2022	Common Stock	23,401	$3.99	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023.
F2	Shares held indirectly by First Amended and Restated Revocable Trust Agreement For The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018).
F3	The Option becomes exercisable in four equal annual installments beginning on April 4, 2023.